SAPIRSTEIN JAMES has filed 13 insider transactions across 4 companies since March 2023.
Most recent transaction: a grant/award of 11066 shares of ZyVersa Therapeutics, Inc. ($ZVSA) on July 11, 2025.
Activity breakdown: 0 open-market purchases and 4 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| July 11, 2025 | ZyVersa Therapeutics, Inc. | $ZVSA | SAPIRSTEIN JAMES | Director | A | Stock Options | 11066 | $0.00 | 11,066.0000 | 2,568,191 | 9999.99% | 0.43% |
| Sept. 26, 2024 | Onconetix, Inc. | $ONCO | SAPIRSTEIN JAMES | Director | A | Common Stock | 3318 | $0.00 | 3,477.0000 | 6,528 | 2086.79% | 50.83% |
| May 24, 2023 | ZyVersa Therapeutics, Inc. | $ZVSA | SAPIRSTEIN JAMES | Director | A | Stock Options | 132 | $0.00 | 132.0000 | 0 | 9999.99% | 0.00% |
| July 2, 2024 | GridAI Technologies Corp. | $GRDX | SAPIRSTEIN JAMES | Chairman and CEO | S | Common Stock | 1289 | $1.07 | 35,816.0000 | 2,294,208 | 3.47% | 0.06% |
| June 25, 2024 | Lunai Bioworks Inc. | $LNAI | SAPIRSTEIN JAMES | Director | A | Option to purchase shares of common stock | 48137 | $0.00 | 48,137.0000 | 0 | 9999.99% | 0.00% |
| April 1, 2024 | GridAI Technologies Corp. | $GRDX | SAPIRSTEIN JAMES | Chairman and CEO | S | Common Stock | 174 | $4.23 | 37,105.0000 | 14,511,461 | 0.47% | 0.00% |
| March 6, 2024 | Lunai Bioworks Inc. | $LNAI | SAPIRSTEIN JAMES | Director | A | Option to Purchase Common Stock | 28196 | $0.00 | 28,196.0000 | 0 | 9999.99% | 0.00% |
| March 15, 2024 | GridAI Technologies Corp. | $GRDX | SAPIRSTEIN JAMES | Chairman and CEO | S | Common Stock | 1887 | $4.96 | 37,279.0000 | 336,342 | 4.82% | 0.56% |
| Jan. 12, 2024 | GridAI Technologies Corp. | $GRDX | SAPIRSTEIN JAMES | Chairman, President and CEO | S | Common Stock | 166 | $4.20 | 39,166.0000 | 336,342 | 0.42% | 0.05% |
| Dec. 29, 2023 | GridAI Technologies Corp. | $GRDX | SAPIRSTEIN JAMES | Chairman, President and CEO | A | Common Stock | 17660 | $0.00 | 19,332.0000 | 378,301 | 1056.22% | 4.67% |
| Jan. 2, 2024 | GridAI Technologies Corp. | $GRDX | SAPIRSTEIN JAMES | Chairman, President and CEO | A | Common Stock | 20000 | $0.00 | 39,332.0000 | 336,342 | 103.46% | 5.95% |
| May 31, 2023 | Onconetix, Inc. | $ONCO | SAPIRSTEIN JAMES | Director | A | Common Stock | 6360 | $0.00 | 6,360.0000 | 15,910,415 | 9999.99% | 0.04% |
| March 6, 2023 | Lunai Bioworks Inc. | $LNAI | SAPIRSTEIN JAMES | Director | A | Option to Purchase Common Stock | 64655 | $0.00 | 64,655.0000 | 0 | 9999.99% | 0.00% |